Informace o projektu
MEDGENET - Medical genomics and epigenomics network
(MEDGENET)
- Kód projektu
- 692298
- Období řešení
- 1/2016 - 12/2018
- Investor / Programový rámec / typ projektu
-
Evropská unie
- Horizon 2020
- Spreading excellence and widening participation
- Fakulta / Pracoviště MU
- Středoevropský technologický institut
- Spolupracující organizace
-
European Molecular Biology Laboratory
Uppsala universitet
Ethniko Kentro Erevnas Kai Technologikis
The main goal of MEDGENET consortium is to use synergies and existing expertise in EU leading institutions such as EMBL, Uppsala University and CERTH to reinforce the productivity and competitiveness of the CEITEC in the field of medical genomics and epigenomics. We propose clear strategy based on combination of unique complementary skills present in partner institutions that will transform CEITEC into a key leader in the field. ERA Chair who recently joint CEITEC already initiated the transformational change of the institute and TWINNING framework will further support sharing her international contacts with other CEITEC researchers. MEDGENET aims to create well-educated taskforce of biomedical researchers, who will notably contribute to the development of new genomics and bioinformatics tools and their application in clinical practice. Proposed project will enable to establish the best practices for performing innovative and high-quality biomedical research and to strengthen CEITEC´s competence to translate the research results into high value-added clinical applications. Stimulation of knowledge exchange, implementation of cutting edge technologies and mastery of modern genomics and bioinformatics methodologies will have a direct impact on the overall research and innovation potential of CEITEC and will increase its visibility in the international scientific community.
Publikace
Počet publikací: 52
2018
-
Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia
BMC Bioinformatics, rok: 2018, ročník: 19, vydání: NOV, DOI
-
CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia
Rok: 2018, druh: Konferenční abstrakty
-
CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo
Rok: 2018, druh: Konferenční abstrakty
-
Dynamics of microRNA expression during early onset epileptogenesis
Rok: 2018, druh: Konferenční abstrakty
-
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
Leukemia, rok: 2018, ročník: 32, vydání: 5, DOI
-
Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes
Rok: 2018, druh: Konferenční abstrakty
-
Gene aberrations in adult patients with Ph-negative ALL in the Czech Republic
Rok: 2018, druh: Konferenční abstrakty
-
Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL
Leukemia, rok: 2018, ročník: 32, vydání: 1, DOI
-
MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels
Rok: 2018, druh: Konferenční abstrakty
-
MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma to DLBCL by upregulating FOXP1 levels
Rok: 2018, druh: Konferenční abstrakty